|
GSK369796 (hydrochloride)---1010411-21-8---现货
- 英文名称：GSK369796
- 品牌：WYTSCI
- 产地：美国
- 型号：1mg
- 货号：WT-DM-C11973
- 纯度：98+
- cas：1010411-21-8
- 发布日期： 2025-04-07
- 更新日期： 2025-05-23
产品详请
| 产地 | 美国 |
| 品牌 | WYTSCI |
| 货号 | WT-DM-C11973 |
| 用途 | 科研检测 |
| 英文名称 | GSK369796 |
| 包装规格 | 1mg |
| CAS编号 | 1010411-21-8 |
| 别名 | GSK369796二盐酸盐 |
| 纯度 | 98+% |
| 分子式 | C20H24Cl3N3O |
| 是否进口 | 是 |
| 货号 | 英文名 | CAS | 别名 |
| WT-DM-C11756 | GSK2795039 | 1415925-18-6 | |
| WT-DM-C11973 | GSK369796 (hydrochloride) | 1010411-21-8 | N-tert-butyl Isoquine |
| WT-DM-C12058 | GSK2838232 | 1443460-91-0 | |
| WT-DM-C12175 | GSK-A1 | 1416334-69-4 | |
| WT-DM-C13351 | GSK1016790A | 942206-85-1 | |
| WT-DM-C19009 | GSK3987 | 264206-85-1 | |
| WT-DM-C19110 | GSK1292263 | 1032823-75-8 | |
| WT-DM-C19111 | GSK2018682 | 1034688-30-6 | |
| WT-DM-C19294 | GSK2033 | 1221277-90-2 | |
| WT-DM-C19479 | GSK805 | 1426802-50-7 | |
| WT-DM-C19486 | GSK0660 | 1014691-61-2 | |
| WT-DM-C19594 | GSK2981278 | 1474110-21-8 | |
| WT-DM-C19783 | GSK2881078 | 1539314-06-1 | |
| WT-DM-C19898 | GSK3787 | 188591-46-0 | |
| WT-DM-C20100 | GSK621 | 1346607-05-3 | |
| WT-DM-C20425 | GSK3368715 (hydrochloride) | 2227587-25-7 | |
| WT-DM-C20499 | GSK626616 | 1025821-33-3 | |
| WT-DM-C20552 | GSK8612 | 2361659-62-1 | |
| WT-DM-C20710 | GSK2982772 | 1622848-92-3 | |
| WT-DM-C20726 | GSK256066 | 801312-28-7 | |
| WT-DM-C20777 | GSK2983559 | 1579965-12-0 | |
| WT-DM-C20940 | GSK180736A | 817194-38-0 | |
| WT-DM-C20980 | GSK2190915 | 936350-00-4 | AM803 |
| WT-DM-C21015 | GSK356278 | 720704-34-7 | |
| WT-DM-C21219 | GSK3117391 | 1018673-42-1 | |
| WT-DM-C21257 | GSK1838705A | 1116235-97-2 | |
| WT-DM-C21311 | GSK3179106 | 1627856-64-7 | RET Kinase Inhibitor 1 |
| WT-DM-C21339 | GSK3326595 | 1616392-22-3 | |
| WT-DM-C21393 | GSK872 | 1346546-69-7 | |
| WT-DM-C21439 | GSK1070916 | 942918-07-2 | |
| WT-DM-C21478 | GSK3β Inhibitor XI | 626604-39-5 | |
| WT-DM-C21523 | GSK2256098 | 1224887-10-8 | |
| WT-DM-C21591 | GSK2269557 | 1254036-77-5 | |
| WT-DM-C21647 | GSK3β Inhibitor XVIII | 1139875-74-3 | |
| WT-DM-C21727 | GSK2837808A | 1445879-21-9 | |
| WT-DM-C21756 | GSK591 | 1616391-87-7 | EPZ015866 |
| WT-DM-C21906 | GSK2656157 | 1337532-29-2 | |
| WT-DM-C21969 | GSK2292767 | 1254036-66-2 | |
| WT-DM-C21974 | GSK269962 | 850664-21-0 | GSK269962A |
| WT-DM-C22036 | GSK3β Inhibitor II | 478482-75-6 | Glycogen Synthase Kinase 3β Inhibitor II |
| WT-DM-C22074 | GSK583 | 1346547-00-9 | |
| WT-DM-C22086 | GSK2879552 | 1401966-69-5 | |
| WT-DM-C22096 | GSK503 | 1346572-63-1 | |
| WT-DM-C22186 | GSK106 (hydrochloride) | 1652591-82-6 | |
| WT-DM-C22189 | GSK121 (trifluoroacetate salt) | 1652591-80-4 | |
| WT-DM-C22264 | GSK2801 | 1619994-68-1 | |
| WT-DM-C22316 | GSK2830371 | 1404456-53-6 | |
| WT-DM-C22331 | GSK923295 | 1088965-37-0 | GSK923295A |
| WT-DM-C22359 | GSK690693 | 937174-76-0 | |
| WT-DM-C22396 | GSK5959 | 901245-65-6 | |
| WT-DM-C22492 | GSK-LSD1 (hydrochloride) | 2102933-95-7 | |
| WT-DM-C22505 | GSK2636771 | 1372540-25-4 | |
| WT-DM-C22592 | GSK3β Inhibitor VIII | 487021-52-3 | AR 014418 |
| WT-DM-C22605 | GSK126 | 1346574-57-9 | |
| WT-DM-C22651 | GSK2578215A | 1285515-21-0 | |
| WT-DM-C22850 | GSK-J2 (sodium salt) | 2108665-15-0 | |
| WT-DM-C22961 | GSK1059615 | 958852-01-2 | |
| WT-DM-C22985 | GSK-J5 (hydrochloride) | 1797983-32-4 | |
| WT-DM-C23000 | GSK-J1 (sodium salt) | 1797832-71-3 | |
| WT-DM-C23925 | GSK2330672 | 1345982-69-5 | |
| WT-DM-C23959 | GSK6853 | 1910124-24-1 | |
| WT-DM-C24870 | GSK2200150A | 1443138-53-1 | |
| WT-DM-C25788 | GSK25 | 874119-56-9 | |
| WT-DM-C25954 | GSK963 | 2049868-46-2 |
